fbpx

Discovery Platform
From Target to Market

Discovery Services

Proven Chemistry

Screening Libraries
1.6M Compounds eShop

Pharmaceutical
Development

Pharmaceutical Development

Why Choose ChemDiv?

  • 25 years experience and 2500 customers worldwide
  • Premium R&D CRO based in USA with global reach
  • Seasoned project managers
  • Extensive Academic partnerships
  • Flexible business models
  • Industry's largest ever-greening stock compound inventory
  • Ongoing investments in novel proprietary chemistry and discovery platforms
Learn More About Us

Our News

Viriom, Inc. announced the initiation of a Phase 2 clinical study to evaluate the efficacy of elsulfavirine in adults with moderate manifestations of COVID-19 (novel coronavirus).
Viriom Launches Reproductive Toxicity Studies for Elpida® (Elsulfavirine) Once Weekly Oral Formulation
New article “A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling”
Read All Our News >

Pharma News

Bristol Myers’ treatment succeeds in late-stage bowel disease study
FDA approves new indication for AstraZeneca’s heart disease drug Brilinta
Emergent BioSolutions, BARDA reach $628M deal to manufacture COVID-19 vaccine hopefuls
Read All Pharma News >

New Products &Services

Target Activity profiling library
MCE-18 Trends in MedChem
Covalent Inhibitors library
RNA Trinucleotide mimetics